Oracle Corporation $ORCL Shares Sold by Eagle Rock Investment Company LLC

Eagle Rock Investment Company LLC decreased its position in Oracle Corporation (NYSE:ORCL) by 41.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 9,719 shares of the enterprise software provider’s stock after selling 6,801 shares during the period. Eagle Rock Investment Company LLC’s holdings in Oracle were worth $1,334,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Catalyst Investment Management LLC grew its holdings in Oracle by 7.1% in the 3rd quarter. Catalyst Investment Management LLC now owns 3,069 shares of the enterprise software provider’s stock worth $421,000 after acquiring an additional 203 shares during the last quarter. Trifecta Capital Advisors LLC raised its stake in shares of Oracle by 2.0% during the third quarter. Trifecta Capital Advisors LLC now owns 34,518 shares of the enterprise software provider’s stock valued at $4,739,000 after acquiring an additional 685 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of Oracle by 4.4% during the third quarter. Crossmark Global Holdings Inc. now owns 288,483 shares of the enterprise software provider’s stock valued at $39,609,000 after acquiring an additional 12,049 shares during the last quarter. Arvest Investments Inc. boosted its holdings in shares of Oracle by 13.5% during the third quarter. Arvest Investments Inc. now owns 3,101 shares of the enterprise software provider’s stock worth $426,000 after purchasing an additional 370 shares during the period. Finally, Guardian Partners Inc. boosted its holdings in shares of Oracle by 0.4% during the third quarter. Guardian Partners Inc. now owns 26,023 shares of the enterprise software provider’s stock worth $3,573,000 after purchasing an additional 116 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ORCL. Citigroup reissued a “market outperform” rating on shares of Oracle in a research note on Friday, October 2nd. Yorkville Ives started coverage on Oracle in a research report on Wednesday, October 7th. They set an “in-line” rating and a $155.00 price target for the company. Argus reiterated a “buy” rating and issued a $225.00 price objective on shares of Oracle in a report on Monday, September 14th. Barclays lifted their price objective on Oracle from $250.00 to $252.00 and gave the stock an “overweight” rating in a research report on Friday, September 11th. Finally, Citizens Jmp reissued a “market outperform” rating and set a $285.00 target price on shares of Oracle in a research note on Friday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, thirty-five have assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $249.52.

Trending Headlines about Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle announced new Fusion Claw-powered agentic HR applications and an AI Agent Studio for building industry-specific agents. The products could strengthen Oracle’s applications business, increase customer productivity and support additional cloud demand. Oracle Introduces Claw-Powered Fusion Agentic Applications for HR
• Positive Sentiment: Southwest General is expanding its use of Oracle Health and Fusion Cloud products, providing evidence of continued adoption across healthcare, finance and operations. Southwest General Expands Relationship with Oracle
• Positive Sentiment: Oracle’s partnership with AstraZeneca to apply AI and real-world data to clinical-trial recruitment expands its healthcare opportunity beyond data-center infrastructure. However, the agreement is exploratory and may take time to generate material revenue. Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
• Neutral Sentiment: Oracle is benefiting from strong AI-cloud enthusiasm, including reports that Nvidia could be helping support financing for Oracle’s data-center buildout. The potential arrangement could ease near-term funding pressure, but it also highlights concerns about Oracle’s leverage, credit rating and dependence on outside financing. TD Cowen Thinks Nvidia Is Helping Oracle Get Its Data Centers Financed
• Negative Sentiment: The main investor concern is that Oracle’s cloud backlog has risen above $664 billion while free cash flow remains deeply negative. Analysts are questioning when the buildout will begin generating cash and whether the valuation adequately compensates investors for execution and financing risks. Oracle’s Growth to Valuation Mismatch is Less and Less Compelling
• Negative Sentiment: Coverage also points to potential customer-concentration and contract risks, including concerns that a significant portion of the backlog may be tied to OpenAI. Comparisons with Salesforce and Microsoft emphasize that Oracle’s faster cloud growth comes with considerably heavier capital spending and debt. Oracle vs. Microsoft: Which Is the Better AI Cloud Stock to Own
• Negative Sentiment: Reports that Oracle is invoking force majeure or reassessing elements of its massive data-center plans reinforce worries about construction delays, power availability and the ability to execute its AI infrastructure commitments. Oracle Calls Force Majeure Already?

Insider Buying and Selling at Oracle

In other news, CEO Michael D. Sicilia sold 22,562 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $151.59, for a total value of $3,420,173.58. Following the completion of the transaction, the chief executive officer owned 182,929 shares of the company’s stock, valued at approximately $27,730,207.11. This represents a 10.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Maria Smith sold 2,631 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total value of $399,122.70. Following the completion of the transaction, the executive vice president owned 64,357 shares of the company’s stock, valued at approximately $9,762,956.90. The trade was a 3.93% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 36,075 shares of company stock valued at $5,342,123. 38.40% of the stock is currently owned by corporate insiders.

Oracle Trading Down 1.6%

NYSE:ORCL opened at $129.10 on Thursday. The company has a 50-day moving average price of $144.17 and a 200-day moving average price of $158.44. Oracle Corporation has a 12 month low of $114.50 and a 12 month high of $287.19. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89. The stock has a market cap of $390.36 billion, a price-to-earnings ratio of 20.24, a P/E/G ratio of 0.93 and a beta of 1.78.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.18. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The company had revenue of $19.34 billion for the quarter, compared to analysts’ expectations of $19.13 billion. During the same quarter in the previous year, the company earned $1.47 earnings per share. Oracle’s quarterly revenue was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Equities analysts predict that Oracle Corporation will post 6.73 EPS for the current year.

Oracle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Friday, October 9th. Oracle’s payout ratio is presently 31.35%.

Oracle Profile

Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company’s offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.